Impact of stroke history on procedural cerebrovascular insult probability and long-term outcome after TAVI.

TAVI severe aortic stenosis stroke

Journal

European journal of clinical investigation
ISSN: 1365-2362
Titre abrégé: Eur J Clin Invest
Pays: England
ID NLM: 0245331

Informations de publication

Date de publication:
Jan 2024
Historique:
revised: 21 08 2023
received: 31 05 2023
accepted: 11 09 2023
pubmed: 29 9 2023
medline: 29 9 2023
entrez: 29 9 2023
Statut: ppublish

Résumé

In TAVI procedural stroke is one of the most feared complications and for this reason also extensively studied. But there is a lack of data concerning the impact of previous stroke on procedural stroke and on long-term survival. The aim of this registry-based cohort study is to evaluate the prevalence of previous stroke in TAVI patients and its impact on procedural stroke risk as well as long-term outcome. We included all patients treated with TAVI between January 2007 and December 2020 and investigated concerning previous stroke in their medical history. Among 958 patients, 55 patients had previous stroke and were included in the present analysis. The salient finding of the present study is that previous stroke is significantly associated with higher all-cause mortality and has established itself as a predictor for poor outcome after TAVI. This is also observed after adjusting for confounders like EuroSCORE II (European system for cardiac operative risk evaluation) and AF (atrial fibrillation) as one of the main underlying diseases for cerebrovascular insult (CVI). However, previous stroke is not associated with higher rates of procedural CVI. A history of stroke is significantly associated with higher all-cause mortality and has established itself as a predictor for poor outcome after TAVI without higher rates of procedural stroke.

Sections du résumé

BACKGROUND BACKGROUND
In TAVI procedural stroke is one of the most feared complications and for this reason also extensively studied. But there is a lack of data concerning the impact of previous stroke on procedural stroke and on long-term survival. The aim of this registry-based cohort study is to evaluate the prevalence of previous stroke in TAVI patients and its impact on procedural stroke risk as well as long-term outcome.
METHODS METHODS
We included all patients treated with TAVI between January 2007 and December 2020 and investigated concerning previous stroke in their medical history. Among 958 patients, 55 patients had previous stroke and were included in the present analysis.
RESULTS RESULTS
The salient finding of the present study is that previous stroke is significantly associated with higher all-cause mortality and has established itself as a predictor for poor outcome after TAVI. This is also observed after adjusting for confounders like EuroSCORE II (European system for cardiac operative risk evaluation) and AF (atrial fibrillation) as one of the main underlying diseases for cerebrovascular insult (CVI). However, previous stroke is not associated with higher rates of procedural CVI.
CONCLUSION CONCLUSIONS
A history of stroke is significantly associated with higher all-cause mortality and has established itself as a predictor for poor outcome after TAVI without higher rates of procedural stroke.

Identifiants

pubmed: 37771050
doi: 10.1111/eci.14099
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14099

Informations de copyright

© 2023 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.

Références

Lee G, Chikwe J, Milojevic M, et al. ESC/EACTS vs. ACC/AHA guidelines for the management of severe aortic stenosis. Eur Heart J. 2023;44(10):796-812. doi:10.1093/eurheartj/ehac803
Ciobanu AO, Gherasim L, Vinereanu D. Risk of stroke after transcatheter aortic valve implantation: epidemiology, mechanism, and management. Am J Ther. 2021;28(5):e560-e572. doi:10.1097/mjt.0000000000001413
Suhai FI, Varga A, Szilveszter B, et al. Predictors and neurological consequences of periprocedural cerebrovascular events following transcatheter aortic valve implantation with self-expanding valves. Front Cardiovasc Med. 2022;9:951943. doi:10.3389/fcvm.2022.951943
De Carlo M, Liga R, Migaleddu G, et al. Evolution, predictors, and neurocognitive effects of silent cerebral embolism during transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2020;13(11):1291-1300. doi:10.1016/j.jcin.2020.03.004
Muntané-Carol G, Urena M, Munoz-Garcia A, et al. Late cerebrovascular events following transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2020;13(7):872-881. doi:10.1016/j.jcin.2019.11.022
Wafa HA, Wolfe CDA, Emmett E, Roth GA, Johnson CO, Wang Y. Burden of stroke in Europe: thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years. Stroke. 2020;51(8):2418-2427. doi:10.1161/strokeaha.120.029606
Wafeu GS, Fozeu L, Ongolo-Zogo P, Menanga AP, Njamnshi AK. Medium-term survival following of stroke in Yaoundé (Cameroon): a prospective observational cohort study. J Stroke Cerebrovasc Dis. 2020;29(9):105060. doi:10.1016/j.jstrokecerebrovasdis.2020.105060
Mérida-Rodrigo L, Poveda-Gómez F, Camafort-Babkowski M, et al. Long-term survival of ischemic stroke. Rev Clin Esp. 2012;212(5):223-228. Supervivencia a largo plazo del ictus isquémico. doi:10.1016/j.rce.2011.12.019
Koton S, Tanne D, Green MS, Bornstein NM. Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004). Neuroepidemiology. 2010;34(2):90-96. doi:10.1159/000264826
Chang KC, Lee HC, Tseng MC, Huang YC. Three-year survival after first-ever ischemic stroke is predicted by initial stroke severity: A hospital-based study. Clin Neurol Neurosurg. 2010;112(4):296-301. doi:10.1016/j.clineuro.2009.12.016
Olszewska K, Tokarek T, Bętkowska-Korpała B, et al. Assessment of cognitive functions and quality of life in patients scheduled for transcatheter aortic valve implantation: a pilot study. Advances in Interventional Cardiology. 2017;13(3):258-262. doi:10.5114/aic.2017.70199
Tokarek TA, Dziewierz A, Sorysz D, et al. The obesity paradox in patients undergoing transcatheter aortic valve implantation: is there any effect of body mass index on survival? Kardiol Pol. 2019;77(2):190-197. doi:10.5603/KP.a2018.0243
Kleiman NS, Maini BJ, Reardon MJ, et al. Neurological events following transcatheter aortic valve replacement and their predictors: a report from the corevalve trials. Circ Cardiovasc Interv. 2016;9(9):e003551. doi:10.1161/circinterventions.115.003551
Eggebrecht H, Schmermund A, Voigtländer T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012;8(1):129-138. doi:10.4244/eijv8i1a20
Levi A, Linder M, Seiffert M, et al. Management and outcome of acute ischemic stroke complicating transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2022;15(18):1808-1819. doi:10.1016/j.jcin.2022.06.033
Seeger J, Kapadia SR, Kodali S, et al. Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis. Eur Heart J. 2019;40(17):1334-1340. doi:10.1093/eurheartj/ehy847
Donà C, Koschutnik M, Nitsche C, et al. Cerebral protection in TAVR-can we do without? A real-world all-comer intention-to-treat study-impact on stroke rate, length of hospital stay, and twelve-month mortality. J Pers Med. 2022;12(2):320. doi:10.3390/jpm12020320
Okuno T, Demirel C, Tomii D, et al. Risk and timing of noncardiac surgery after transcatheter aortic valve implantation. JAMA Netw Open. 2022;5(7):e2220689. doi:10.1001/jamanetworkopen.2022.20689
Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J. 2012;33(19):2403-2418. doi:10.1093/eurheartj/ehs255

Auteurs

Caglayan Demirel (C)

Department of Internal Medicine II, Clinical Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Patrick Sulzgruber (P)

Department of Internal Medicine II, Clinical Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Max Paul Winter (MP)

Department of Internal Medicine II, Clinical Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Katharina Mascherbauer (K)

Department of Internal Medicine II, Clinical Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Kseniya Halavina (K)

Department of Internal Medicine II, Clinical Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Gregor Heitzinger (G)

Department of Internal Medicine II, Clinical Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Carolina Dona (C)

Department of Internal Medicine II, Clinical Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Sophia Koschatko (S)

Department of Internal Medicine II, Clinical Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Charlotte Jantsch (C)

Department of Internal Medicine II, Clinical Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Martin Andreas (M)

Department of Cardiac Surgery, Medical University Vienna, Vienna, Austria.

Christian Hengstenberg (C)

Department of Internal Medicine II, Clinical Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Philipp E Bartko (PE)

Department of Internal Medicine II, Clinical Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Classifications MeSH